Cargando…
Clinical impact using low-dose mycophenolate mofetil with tacrolimus on infectious, noninfectious complications and acute rejection, in renal transplant: A single hospital experience in Mexico
Evidence supporting a starting dose of 2 g/day of mycophenolate mofetil (MMF) in combination with tacrolimus (TAC) for renal transplantation (RT) is still limited, but maintaining a dose of <2 g could result in worse clinical outcomes in terms of acute rejection (AR). This study aimed to determin...
Autores principales: | Andrade-Sierra, Jorge, Hernández-Reyes, Hernesto, Rojas-Campos, Enrique, Cardona-Muñoz, Ernesto Germán, Cerrillos-Gutiérrez, José Ignacio, González-Espinoza, Eduardo, Evangelista-Carrillo, Luis Alberto, Medina-Pérez, Miguel, Jalomo-Martínez, Basilio, Miranda-Díaz, Alejandra Guillermina, Martínez-Mejía, Víctor Manuel, Gómez-Navarro, Benjamin, Andrade-Ortega, Antonio de Jesús, Nieves-Hernández, Juan José, Mendoza-Cerpa, Claudia Alejandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10659689/ https://www.ncbi.nlm.nih.gov/pubmed/37986377 http://dx.doi.org/10.1097/MD.0000000000035841 |
Ejemplares similares
-
Role of tacrolimus combination therapy with mycophenolate mofetil in the prevention of organ rejection in kidney transplant patients
por: Dalal, P, et al.
Publicado: (2010) -
Mycophenolate-mofetil/prednisone/tacrolimus: Infections: case report
Publicado: (2020) -
Mycophenolate mofetil/tacrolimus: Cutaneous leishmaniasis: case report
Publicado: (2021) -
Mycophenolate-mofetil/tacrolimus: COVID-19: case report
Publicado: (2022) -
Mycophenolate mofetil/tacrolimus: COVID-19 infection: case report
Publicado: (2021)